Supply Chain Mapping
Maintain GxP Compliance
The EU currently consists of 27-Member States; each has its own market nuances for importation, transportation and distribution of pharmaceutical materials that will need to be addressed. There is significant complexity to navigate in determining a commercialisation strategy for the EU. Supply chain mapping and optimisation of the supply chain structure to facilitate GxP compliance can deliver significant financial savings over the life cycle of a product.
OUR SUPPLY CHAIN APPROACH
MIAS takes a two-phase approach to supply chain mapping for our customers:
SUPPORT & ADVISE
MIAS Workshops
In preparation of this workshop we advise our clients to:
SUPPORT & ADVISE
Oversight & Compliance
“It is the ultimate responsibility of the MAH to ensure that the medicinal product is designed and developed ethically, taking into account the requirements of Good Manufacturing Practices and Good Laboratory Practices. Ensuring the security and GMP compliance of the entire manufacturing supply chain is an important responsibility of the MAH to ensure appropriate and continued availability of medicinal products for human use to meet the needs of patients in accordance with Article 81 of Directive 2001/83.”
On request, MIAS can work with your company’s existing service providers and provide a turnkey solution including selection and qualification of the most appropriate alliance partners for each stage of the project and provide full project management & oversight of the supply chain to ensure that best practice is maintained by all suppliers.